论文部分内容阅读
原发性肝癌(PHC)灶我国常见的恶性肿瘤之一,死亡率高,平均生存期短。对PHC的防治是医学界研究重点。70年代以来,国内在对PHC的病因探讨、动物模型试验、现场调查、早期诊断、早期治疗等方面作了大量工作。目前,对肝癌的研究我们是处于国际领先地位,尤其在早期诊断方面,1986年上海国际肝癌与肝炎会议,受到国际医学科学工作者的一致好评。对PHC的诊断包括定性诊断和定位诊断两方面。一、定性诊断α-甲胎蛋白(AFP):6O年代后期开外始用于PHC的诊断,一直被公认是一种简便、迅速、阳性率高(70～90％)的一项定性指标。AFP单项诊断PHC的
One of the common malignancies in primary liver cancer (PHC) foci is high mortality and short survival. The prevention and treatment of PHC is the focus of medical research. Since the 1970s, a lot of work has been done on the etiology of PHC, animal model tests, field investigations, early diagnosis, and early treatment. At present, we are in a leading position in the research of liver cancer, especially in early diagnosis. In 1986, the Shanghai International Conference on Liver Cancer and Hepatitis was received by international medical scientists. The diagnosis of PHC includes qualitative diagnosis and location diagnosis. I. Qualitative diagnosis of alpha-fetoprotein (AFP): The diagnosis of PHC in the late 6O’s has been widely accepted as a simple, rapid, positive rate (70 to 90%). AFP individual diagnosis of PHC